1. Home
  2. MTNB

as 09-17-2025 12:34pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.

Founded: 2013 Country:
United States
United States
Employees: N/A City: BEDMINSTER
Market Cap: 9.7M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 118.5K
Analyst Decision: Hold Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -3.86 EPS Growth: N/A
52 Week Low/High: $0.47 - $4.25 Next Earning Date: 11-12-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

MTNB Daily Stock ML Predictions

Share on Social Networks: